Company Filing History:
Years Active: 2016
Title: Susan Wee: Innovator in Pharmaceutical Combinations
Introduction
Susan Wee is a notable inventor based in Skillman, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of proliferative diseases. Her innovative work focuses on combining specific inhibitors and modulators to enhance therapeutic efficacy.
Latest Patents
Susan Wee holds 1 patent for her invention titled "Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway." This invention relates to a pharmaceutical combination that includes a phosphoinositide 3-kinase inhibitor and a compound that modulates the Ras/Raf/Mek pathway. The combination is designed for the treatment of solid tumor diseases, offering a promising approach to combat proliferative diseases. The patent also covers the pharmaceutical composition, its use in preparing medicaments, and methods for treating warm-blooded animals, especially humans.
Career Highlights
Susan is currently associated with Novartis AG, a leading global healthcare company. Her role involves research and development in innovative therapeutic solutions. Her work has been instrumental in advancing treatment options for patients suffering from various diseases.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues, including Carlos Garcia-Echeverria and Sauveur-Michel Maira. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
Susan Wee's contributions to pharmaceutical innovations highlight her commitment to improving treatment options for proliferative diseases. Her work exemplifies the impact of combining scientific research with practical applications in medicine.